$THC
TENET HEALTHCARE CORP Stock $thc

$thc Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000007031820000036 Filed on August 03, 2020

Income Statement

Concept	2020 Q2	2019 Q2
Revenue	$3.648B	$4.560B
YoY Change	-20.0%	1.2%
Cost Of Revenue	$611.0M	$753.0M
YoY Change	-18.86%	0.67%
Gross Profit	$3.037B	$3.807B
YoY Change	-20.23%	1.3%
Gross Profit Margin	83.25%	83.49%
Selling, General & Admin	$1.864B	$2.145B
YoY Change	-13.1%	0.47%
% of Gross Profit	61.38%	56.34%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$206.0M	$214.0M
YoY Change	-3.74%	10.31%
% of Gross Profit	6.78%	5.62%
Operating Expenses	$3.053B	$3.394B
YoY Change	-10.05%	1.13%
Operating Profit	$471.0M	$400.0M
YoY Change	17.75%	-1.48%
Interest Expense	$255.0M	$247.0M
YoY Change	3.24%	-2.76%
% of Operating Profit	54.14%	61.75%
Other Income/Expense, Net	$2.000M	-$1.000M
YoY Change	-300.0%	0.0%
Pretax Income	$214.0M	$152.0M
YoY Change	40.79%	1.33%
Income Tax	$45.00M	$33.00M
% Of Pretax Income	21.03%	21.71%
Net Earnings	$169.0M	$121.0M
YoY Change	39.67%	12.04%
Net Earnings / Revenue	4.63%	2.65%
Basic Earnings Per Share	$0.84	$0.25
Diluted Earnings Per Share	$0.83	$0.25
COMMON SHARES
Basic Shares Outstanding	104.8M shares	103.2M shares
Diluted Shares Outstanding	105.6M shares	104.6M shares

Balance Sheet

Concept	2020 Q2	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.514B	$249.0M
YoY Change	1311.24%	-38.21%
Cash & Equivalents	$3.514B	$249.0M
Short-Term Investments
Other Short-Term Assets	$1.265B	$1.393B
YoY Change	-9.19%	33.81%
Inventory	$337.0M	$309.0M
Prepaid Expenses
Receivables	$2.435B	$2.734B
Other Receivables	$18.00M	$19.00M
Total Short-Term Assets	$7.947B	$4.704B
YoY Change	68.94%	-0.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.703B	$6.995B
YoY Change	-4.17%	1.92%
Goodwill	$7.301B	$7.298B
YoY Change	0.04%	1.11%
Intangibles	$1.603B	$1.645B
YoY Change	-2.55%	-8.25%
Long-Term Investments	$2.464B	$1.423B
YoY Change	73.16%	0.49%
Other Assets	$232.0M	$268.0M
YoY Change	-13.43%	-22.99%
Total Long-Term Assets	$18.30B	$18.50B
YoY Change	-1.08%	4.9%
TOTAL ASSETS
Total Short-Term Assets	$7.947B	$4.704B
Total Long-Term Assets	$18.30B	$18.50B
Total Assets	$26.25B	$23.21B
YoY Change	13.11%	3.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.018B	$1.088B
YoY Change	-6.43%	3.92%
Accrued Expenses	$956.0M	$1.102B
YoY Change	-13.25%	15.51%
Deferred Revenue	$1.496B
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$160.0M	$664.0M
YoY Change	-75.9%	0.15%
Total Short-Term Liabilities	$5.585B	$4.150B
YoY Change	34.58%	-4.69%
LONG-TERM LIABILITIES
Long-Term Debt	$15.73B	$14.31B
YoY Change	9.89%	0.76%
Other Long-Term Liabilities	$1.526B	$1.354B
YoY Change	12.7%	126.04%
Total Long-Term Liabilities	$1.526B	$1.354B
YoY Change	12.7%	126.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.585B	$4.150B
Total Long-Term Liabilities	$1.526B	$1.354B
Total Liabilities	$24.06B	$21.03B
YoY Change	14.4%	3.39%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.346B	-$2.237B
YoY Change	4.87%	0.68%
Common Stock	$7.000M	$7.000M
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$257.0M	-$108.0M
YoY Change
Total Liabilities & Shareholders Equity	$26.25B	$23.21B
YoY Change	13.11%	3.87%

Cashflow Statement

Concept	2020 Q2	2019 Q2
OPERATING ACTIVITIES
Net Income	$169.0M	$121.0M
YoY Change	39.67%	12.04%
Depreciation, Depletion And Amortization	$206.0M	$214.0M
YoY Change	-3.74%	10.31%
Cash From Operating Activities	$2.239B	$284.0M
YoY Change	688.38%	-18.39%
INVESTING ACTIVITIES
Capital Expenditures	$106.0M	$144.0M
YoY Change	-26.39%	-215.2%
Acquisitions
YoY Change
Other Investing Activities	$21.00M	-$20.00M
YoY Change	-205.0%	-13.04%
Cash From Investing Activities	-$85.00M	-$164.0M
YoY Change	-48.17%	10.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	747.0M	-123.0M
YoY Change	-707.32%	-84.05%
NET CHANGE
Cash From Operating Activities	2.239B	284.0M
Cash From Investing Activities	-85.00M	-164.0M
Cash From Financing Activities	747.0M	-123.0M
Net Change In Cash	2.901B	-3.000M
YoY Change	-96800.0%	-99.47%
FREE CASH FLOW
Cash From Operating Activities	$2.239B	$284.0M
Capital Expenditures	$106.0M	$144.0M
Free Cash Flow	$2.133B	$140.0M
YoY Change	1423.57%	-70.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000070318
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Period End Date DocumentPeriodEndDate	2020-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201613Member
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	1-7293
	dei	Entity Registrant Name EntityRegistrantName	TENET HEALTHCARE CORP
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-2557091
	dei	Entity Address Address Line1 EntityAddressAddressLine1	14201 Dallas Parkway
	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75254
	dei	City Area Code CityAreaCode	469
	dei	Local Phone Number LocalPhoneNumber	893-2200
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	105389222	shares
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3514000000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	262000000	USD
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2435000000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2743000000	USD
CY2020Q2	us-gaap	Inventory Net InventoryNet	337000000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	310000000	USD
CY2020Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	18000000	USD
CY2020Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1265000000	USD
CY2019Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	10000000	USD
CY2020Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	378000000	USD
CY2019Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	387000000	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1369000000	USD
CY2020Q2	us-gaap	Assets Current AssetsCurrent	7947000000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	5081000000	USD
CY2020Q2	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2464000000	USD
CY2019Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2369000000	USD
CY2020Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	232000000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	183000000	USD
CY2020Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	5759000000	USD
CY2019Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	5498000000	USD
CY2020Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	6703000000	USD
CY2019Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	6878000000	USD
CY2020Q2	us-gaap	Goodwill Goodwill	7301000000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	7252000000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1163000000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1092000000	USD
CY2020Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1603000000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1602000000	USD
CY2020Q2	us-gaap	Assets Assets	26250000000	USD
CY2019Q4	us-gaap	Assets Assets	23365000000	USD
CY2020Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	160000000	USD
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	171000000	USD
CY2020Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1018000000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1204000000	USD
CY2020Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	699000000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	877000000	USD
CY2020Q2	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	292000000	USD
CY2019Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	330000000	USD
CY2020Q2	us-gaap	Interest Payable Current InterestPayableCurrent	257000000	USD
CY2019Q4	us-gaap	Interest Payable Current InterestPayableCurrent	245000000	USD
CY2020Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	93000000	USD
CY2019Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	44000000	USD
CY2020Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1496000000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	61000000	USD
CY2020Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1570000000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1273000000	USD
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5585000000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4205000000	USD
CY2020Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	15728000000	USD
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	14580000000	USD
CY2020Q2	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	649000000	USD
CY2019Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	635000000	USD
CY2020Q2	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	541000000	USD
CY2019Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	560000000	USD
CY2020Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	27000000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	27000000	USD
CY2020Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1526000000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1415000000	USD
CY2020Q2	us-gaap	Liabilities Liabilities	24056000000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	21422000000	USD
CY2020Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	1561000000	USD
CY2019Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	1506000000	USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	262500000	shares
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	262500000	shares
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	153242552	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	152540815	shares
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	7000000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	7000000	USD
CY2020Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4751000000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4760000000	USD
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-255000000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-257000000	USD
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2346000000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2513000000	USD
CY2020Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	48341041	shares
CY2019Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	48344195	shares
CY2020Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2414000000	USD
CY2019Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2414000000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-257000000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-417000000	USD
CY2020Q2	us-gaap	Minority Interest MinorityInterest	890000000	USD
CY2019Q4	us-gaap	Minority Interest MinorityInterest	854000000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	633000000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	437000000	USD
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26250000000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23365000000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3648000000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4560000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8168000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9105000000	USD
CY2020Q2	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	511000000	USD
CY2019Q2	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	0	USD
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	511000000	USD
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	0	USD
CY2020Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	31000000	USD
CY2019Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	42000000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	59000000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	76000000	USD
CY2020Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1864000000	USD
CY2019Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2145000000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4051000000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4296000000	USD
CY2020Q2	us-gaap	Supplies Expense SuppliesExpense	611000000	USD
CY2019Q2	us-gaap	Supplies Expense SuppliesExpense	753000000	USD
	us-gaap	Supplies Expense SuppliesExpense	1374000000	USD
	us-gaap	Supplies Expense SuppliesExpense	1494000000	USD
CY2020Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	983000000	USD
CY2019Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1035000000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1996000000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	2100000000	USD
CY2020Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	206000000	USD
CY2019Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	214000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	409000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	422000000	USD
CY2020Q2	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	54000000	USD
CY2019Q2	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	36000000	USD
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	109000000	USD
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	55000000	USD
CY2020Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-2000000	USD
CY2019Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-18000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-4000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-31000000	USD
CY2020Q2	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	1000000	USD
CY2019Q2	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	-1000000	USD
	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	3000000	USD
	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	-2000000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	471000000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	400000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	798000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	781000000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	255000000	USD
CY2019Q2	us-gaap	Interest Expense InterestExpense	247000000	USD
	us-gaap	Interest Expense InterestExpense	498000000	USD
	us-gaap	Interest Expense InterestExpense	498000000	USD
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2000000	USD
CY2019Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3000000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2020Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4000000	USD
CY2019Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4000000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-47000000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	214000000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	152000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	299000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	236000000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	45000000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-30000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53000000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	169000000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	119000000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	329000000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	183000000	USD
CY2020Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	0	USD
CY2019Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	2000000	USD
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-1000000	USD
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	12000000	USD
CY2020Q2	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	0	USD
CY2019Q2	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	0	USD
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	0	USD
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	2000000	USD
CY2020Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	USD
CY2019Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	2000000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1000000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	10000000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	169000000	USD
CY2019Q2	us-gaap	Profit Loss ProfitLoss	121000000	USD
	us-gaap	Profit Loss ProfitLoss	328000000	USD
	us-gaap	Profit Loss ProfitLoss	193000000	USD
CY2020Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	81000000	USD
CY2019Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	95000000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	147000000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	179000000	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	88000000	USD
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	26000000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	181000000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	14000000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	88000000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	24000000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	182000000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4000000	USD
CY2020Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
CY2019Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	2000000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1000000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	10000000	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	88000000	USD
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	26000000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	181000000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	14000000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.84
CY2019Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.23
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.74
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.04
CY2020Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2019Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.02
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.10
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.84
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.73
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2020Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.83
CY2019Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.23
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.72
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.04
CY2020Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2019Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.02
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.10
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.83
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.71
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104794000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103198000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104574000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	102993000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105578000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104629000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105656000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104585000	shares
CY2020Q2	us-gaap	Profit Loss ProfitLoss	169000000	USD
CY2019Q2	us-gaap	Profit Loss ProfitLoss	121000000	USD
	us-gaap	Profit Loss ProfitLoss	328000000	USD
	us-gaap	Profit Loss ProfitLoss	193000000	USD
CY2020Q2	thc	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Amortization Of Net Actuarial Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax	2000000	USD
CY2019Q2	thc	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Amortization Of Net Actuarial Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax	3000000	USD
	thc	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Amortization Of Net Actuarial Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax	4000000	USD
	thc	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Amortization Of Net Actuarial Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax	6000000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	0	USD
CY2019Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1000000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	0	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	2000000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	3000000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	5000000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	6000000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1000000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1000000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	3000000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	2000000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1000000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4000000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	170000000	USD
CY2019Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	123000000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	330000000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	197000000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	81000000	USD
CY2019Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	95000000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	147000000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	179000000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	89000000	USD
CY2019Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	28000000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	183000000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	18000000	USD
	us-gaap	Profit Loss ProfitLoss	328000000	USD
	us-gaap	Profit Loss ProfitLoss	193000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	409000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	422000000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-49000000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	48000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	27000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	23000000	USD
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	109000000	USD
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	55000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-4000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-31000000	USD
	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	3000000	USD
	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	-2000000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4000000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-47000000	USD
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	39000000	USD
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	2000000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	20000000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	21000000	USD
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-1000000	USD
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	12000000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3000000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	10000000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-317000000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	138000000	USD
	thc	Increase Decrease In Inventories And Other Assets Current IncreaseDecreaseInInventoriesAndOtherAssetsCurrent	-44000000	USD
	thc	Increase Decrease In Inventories And Other Assets Current IncreaseDecreaseInInventoriesAndOtherAssetsCurrent	64000000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-14000000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	2000000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1209000000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-239000000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	90000000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	4000000	USD
	thc	Payments For Restructuring And Litigation Costs PaymentsForRestructuringAndLitigationCosts	114000000	USD
	thc	Payments For Restructuring And Litigation Costs PaymentsForRestructuringAndLitigationCosts	80000000	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	0	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-5000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2368000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	294000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	288000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	336000000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	56000000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	13000000	USD
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	12000000	USD
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	40000000	USD
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	USD
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	17000000	USD
	thc	Proceeds From Sale Of Marketable Securities Long Term Investments And Other Assets ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets	35000000	USD
	thc	Proceeds From Sale Of Marketable Securities Long Term Investments And Other Assets ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets	9000000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	10000000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	14000000	USD
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	0	USD
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	4000000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-18000000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	2000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-289000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-303000000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	740000000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	1095000000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	740000000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	1285000000	USD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	229000000	USD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	1668000000	USD
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	1312000000	USD
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	1516000000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	22000000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	18000000	USD
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	100000000	USD
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	144000000	USD
	us-gaap	Proceeds From Sale Of Interest In Corporate Unit ProceedsFromSaleOfInterestInCorporateUnit	5000000	USD
	us-gaap	Proceeds From Sale Of Interest In Corporate Unit ProceedsFromSaleOfInterestInCorporateUnit	9000000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	6000000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	5000000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	3000000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	202000000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-35000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1173000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-153000000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3252000000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-162000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	262000000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	411000000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3514000000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	249000000	USD
	us-gaap	Interest Paid Net InterestPaidNet	465000000	USD
	us-gaap	Interest Paid Net InterestPaidNet	484000000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-5000000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-13000000	USD
	thc	Number Of Hospitals Operated By Subsidiaries NumberOfHospitalsOperatedBySubsidiaries	65	hospital
	thc	Number Of Healthcare Facilities NumberOfHealthcareFacilities	510	center
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	183000000	USD
CY2019Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	635000000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1415000000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2513000000	USD
CY2020Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1864000000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4051000000	USD
CY2020Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	983000000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1996000000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	471000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	798000000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	45000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-30000000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	169000000	USD
	us-gaap	Profit Loss ProfitLoss	328000000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	88000000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	182000000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.84
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.74
CY2020Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.83
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.72
CY2019Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2145000000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4296000000	USD
CY2019Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1035000000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	2100000000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	400000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	781000000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53000000	USD
CY2019Q2	us-gaap	Profit Loss ProfitLoss	121000000	USD
	us-gaap	Profit Loss ProfitLoss	193000000	USD
	us-gaap	Profit Loss ProfitLoss	193000000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	24000000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4000000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.23
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.04
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.04
CY2019Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.23
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.04
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.04
	us-gaap	Profit Loss ProfitLoss	328000000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-49000000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1209000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2368000000	USD
	us-gaap	Profit Loss ProfitLoss	193000000	USD
	us-gaap	Profit Loss ProfitLoss	193000000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	48000000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-239000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	294000000	USD
CY2020Q2	thc	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	712000000	USD
CY2020Q2	us-gaap	Deferred Revenue DeferredRevenue	163000000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3514000000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	262000000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	45000000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	136000000	USD
	thc	Finance Lease Liability Incurred FinanceLeaseLiabilityIncurred	43000000	USD
	thc	Finance Lease Liability Incurred FinanceLeaseLiabilityIncurred	58000000	USD
	thc	Operating Lease Liability Incurred OperatingLeaseLiabilityIncurred	88000000	USD
	thc	Operating Lease Liability Incurred OperatingLeaseLiabilityIncurred	139000000	USD
CY2020Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2766000000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1163000000	USD
CY2020Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1603000000	USD
CY2019Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2694000000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1092000000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1602000000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	922000000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	87000000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	132000000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	118000000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	106000000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	88000000	USD
CY2020Q2	thc	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	391000000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	79000000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	90000000	USD
	thc	Percentage Investee Results Reflected PercentageInvesteeResultsReflected	1
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2435000000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2743000000	USD
CY2020Q2	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	188000000	USD
CY2019Q2	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	205000000	USD
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	109000000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5000000	USD
	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	384000000	USD
	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	397000000	USD
CY2020Q2	thc	Contract With Customer Asset Percentage To Be Reclassified To Receivable Within90 Days ContractWithCustomerAssetPercentageToBeReclassifiedToReceivableWithin90Days	0.85
CY2019Q2	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1000000	USD
CY2020Q2	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1000000	USD
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2000000	USD
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2000000	USD
CY2019Q4	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	25000000	USD
CY2020Q2	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	25000000	USD
CY2020Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	93000000	USD
	us-gaap	Restructuring Costs RestructuringCosts	103000000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1000000	USD
	us-gaap	Severance Costs1 SeveranceCosts1	37000000	USD
	us-gaap	Business Exit Costs1 BusinessExitCosts1	1000000	USD
	us-gaap	Other Restructuring Costs OtherRestructuringCosts	17000000	USD
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	55000000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5000000	USD
	us-gaap	Restructuring Costs RestructuringCosts	47000000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3000000	USD
	us-gaap	Severance Costs1 SeveranceCosts1	18000000	USD
	us-gaap	Business Exit Costs1 BusinessExitCosts1	2000000	USD
	us-gaap	Other Restructuring Costs OtherRestructuringCosts	27000000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2020Q2	thc	Finance Leases And Mortgage Notes FinanceLeasesAndMortgageNotes	417000000	USD
CY2019Q4	thc	Finance Leases And Mortgage Notes FinanceLeasesAndMortgageNotes	445000000	USD
CY2020Q2	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	15888000000	USD
CY2019Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	14751000000	USD
CY2020Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	160000000	USD
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	171000000	USD
CY2020Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	15728000000	USD
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	14580000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	27000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23000000	USD
CY2020Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	2000000	USD
	thc	Number Of Frozen Non Qualified Defined Benefit Pension Plans NumberOfFrozenNonQualifiedDefinedBenefitPensionPlans	1	plan
	thc	Number Of Frozen Non Qualified Defined Benefit Pension Plans NumberOfFrozenNonQualifiedDefinedBenefitPensionPlans	1	plan
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	437000000	USD
CY2020Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	125000000	USD
CY2020Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	40000000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1000000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	1000000	USD
CY2020Q1	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	-15000000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	10000000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	503000000	USD
CY2020Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	123000000	USD
CY2020Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	8000000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1000000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	2000000	USD
CY2020Q2	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	0	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	16000000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	633000000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	624000000	USD
CY2019Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	25000000	USD
CY2019Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	37000000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2000000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	5000000	USD
CY2019Q1	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	0	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8000000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	618000000	USD
CY2019Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	73000000	USD
CY2019Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	35000000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2000000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	4000000	USD
CY2019Q2	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	5000000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	11000000	USD
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	670000000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	214000000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	152000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	299000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	236000000	USD
CY2020Q2	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	45000000	USD
CY2019Q2	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	32000000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	63000000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	50000000	USD
CY2020Q2	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	10000000	USD
CY2019Q2	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	6000000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	35000000	USD
CY2020Q2	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	4000000	USD
CY2019Q2	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	2000000	USD
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	15000000	USD
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	9000000	USD
CY2020Q2	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	16000000	USD
CY2019Q2	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	19000000	USD
	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	30000000	USD
	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	36000000	USD
CY2020Q2	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	0	USD
CY2019Q2	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	0	USD
	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-3000000	USD
	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	1000000	USD
CY2020Q2	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	0	USD
CY2019Q2	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1000000	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	0	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	0	USD
CY2020Q2	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2000000	USD
CY2019Q2	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	11000000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-88000000	USD
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	7000000	USD
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-4000000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	45000000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-30000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53000000	USD
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-88000000	USD
	thc	Income Tax Expense Benefit Due To Increase Decrease In Liabilities For Uncertain Tax Positions IncomeTaxExpenseBenefitDueToIncreaseDecreaseInLiabilitiesForUncertainTaxPositions	0	USD
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	31000000	USD
CY2020Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	29000000	USD
CY2020Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2020Q2	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	0	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	88000000	USD
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104794000	shares
CY2020Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.84
CY2020Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	784000	shares
CY2020Q2	thc	Effect Of Dilutive Stock Options Restricted Stock Units And Mandatory Convertible Preferred Stock Per Share Amount EffectOfDilutiveStockOptionsRestrictedStockUnitsAndMandatoryConvertiblePreferredStockPerShareAmount	-0.01
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	88000000	USD
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105578000	shares
CY2020Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.83
CY2019Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	24000000	USD
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103198000	shares
CY2019Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.23
CY2019Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1431000	shares
CY2019Q2	thc	Effect Of Dilutive Stock Options Restricted Stock Units And Mandatory Convertible Preferred Stock Per Share Amount EffectOfDilutiveStockOptionsRestrictedStockUnitsAndMandatoryConvertiblePreferredStockPerShareAmount	0
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	24000000	USD
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104629000	shares
CY2019Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.23
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	182000000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104574000	shares
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.74
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1082000	shares
	thc	Effect Of Dilutive Stock Options Restricted Stock Units And Mandatory Convertible Preferred Stock Per Share Amount EffectOfDilutiveStockOptionsRestrictedStockUnitsAndMandatoryConvertiblePreferredStockPerShareAmount	-0.02
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	182000000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105656000	shares
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.72
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4000000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	102993000	shares
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.04
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1592000	shares
	thc	Effect Of Dilutive Stock Options Restricted Stock Units And Mandatory Convertible Preferred Stock Per Share Amount EffectOfDilutiveStockOptionsRestrictedStockUnitsAndMandatoryConvertiblePreferredStockPerShareAmount	0
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	4000000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104585000	shares
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.04
	thc	Number Of Hospitals Operated By Subsidiaries NumberOfHospitalsOperatedBySubsidiaries	65	hospital
CY2020Q2	us-gaap	Assets Assets	26250000000	USD
CY2019Q4	us-gaap	Assets Assets	23365000000	USD
CY2020Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	106000000	USD
CY2019Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	144000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	288000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	336000000	USD
CY2020Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-2000000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3648000000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4560000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8168000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9105000000	USD
CY2020Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	31000000	USD
CY2019Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	42000000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	59000000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	76000000	USD
CY2020Q2	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	732000000	USD
CY2019Q2	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	669000000	USD
	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	1317000000	USD
	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	1292000000	USD
CY2020Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	206000000	USD
CY2019Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	214000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	409000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	422000000	USD
CY2020Q2	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	732000000	USD
CY2019Q2	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	669000000	USD
	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	1317000000	USD
	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	1292000000	USD
CY2020Q2	thc	Income Loss From Divested And Closed Businesses IncomeLossFromDivestedAndClosedBusinesses	0	USD
CY2019Q2	thc	Income Loss From Divested And Closed Businesses IncomeLossFromDivestedAndClosedBusinesses	0	USD
	thc	Income Loss From Divested And Closed Businesses IncomeLossFromDivestedAndClosedBusinesses	0	USD
	thc	Income Loss From Divested And Closed Businesses IncomeLossFromDivestedAndClosedBusinesses	-1000000	USD
CY2020Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	206000000	USD
CY2019Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	214000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	409000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	422000000	USD
CY2020Q2	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	54000000	USD
CY2019Q2	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	36000000	USD
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	109000000	USD
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	55000000	USD
CY2019Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-18000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-4000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-31000000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	255000000	USD
CY2019Q2	us-gaap	Interest Expense InterestExpense	247000000	USD
	us-gaap	Interest Expense InterestExpense	498000000	USD
	us-gaap	Interest Expense InterestExpense	498000000	USD
CY2020Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4000000	USD
CY2019Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4000000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-47000000	USD
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2000000	USD
CY2019Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3000000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2020Q2	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	1000000	USD
CY2019Q2	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	-1000000	USD
	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	3000000	USD
	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	-2000000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	214000000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	152000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	299000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	236000000	USD

Files In Submission

Name	View Source	Status
0000070318-20-000036-index-headers.html	Edgar Link	pending
0000070318-20-000036-index.html	Edgar Link	pending
0000070318-20-000036.txt	Edgar Link	pending
0000070318-20-000036-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
thc-20200630.htm	Edgar Link	pending
thc-20200630.xsd	Edgar Link	pending
thc-20200630ex31a.htm	Edgar Link	pending
thc-20200630ex31b.htm	Edgar Link	pending
thc-20200630ex32.htm	Edgar Link	pending
thc-20200630_cal.xml	Edgar Link	unprocessable
thc-20200630_def.xml	Edgar Link	unprocessable
thc-20200630_htm.xml	Edgar Link	completed
thc-20200630_lab.xml	Edgar Link	unprocessable
thc-20200630_pre.xml	Edgar Link	unprocessable
thc20200630ex10a.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$THC
TENET HEALTHCARE CORP Stock $thc

2020 Q2 Form 10-Q Financial Statement

#000007031820000036 Filed on August 03, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THC TENET HEALTHCARE CORP Stock $thc

2020 Q2 Form 10-Q Financial Statement

#000007031820000036 Filed on August 03, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THC
TENET HEALTHCARE CORP Stock $thc